Remove 2011 Remove Healthcare Remove Leads
article thumbnail

Sorry, the Inflation Bill won’t lower healthcare costs

World of DTC Marketing

The Inflation Reduction Act’s health insurance subsidies and drug pricing reforms will improve health care affordability for Americans but won’t do a damn thing for our overall healthcare costs, which will keep rising. This is going to lead to a lot of health problems and associated costs. One in 4 U.S. percent of U.S.

article thumbnail

New FDA head needs to examine the accelerated approval program

World of DTC Marketing

A separate analysis by the same research team, also published Monday by JAMA Internal Medicine, found that in 2018, nearly 60% of cancer patients with private insurance nationally received an oral targeted treatment that did not lead to improved overall survival in clinical trials. appeared first on World of DTC Marketing.com.

FDA 234
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The EU HTA regulation: a new frontier for access to innovative technologies

European Pharmaceutical Review

To achieve this objective, the regulation amends Directive 2011/24/EU on the application of patients’ rights in cross?border border healthcare, specifically by repealing Article 15, which originally laid down the modalities and principles for co-operation between Member States in assessing new health technologies. About the authors.

article thumbnail

Why Are Patients So Angry? Plus, Frontliner Tips for Health Leaders

Healthcare Success

But first, we must understand what’s happening in healthcare and the world-at-large post-pandemic. To be clear, workplace violence experienced by healthcare workers predates the pandemic. The rate of injuries from violent attacks against medical professionals grew by 63% from 2011 to 2018. Technology overuse Ms.

Patients 109
article thumbnail

Five Years of Forbes | Legacy MEDSearch Ranks on the Forbes Best Executive Recruitment Firms for a Fifth Consecutive Year

Legacy MEDSearch

Leadership includes Joy Celebre (recruiting since 1996, joined in 2008), Carolyn Jones (recruiting since 1995, joined in 2011), Arshad Alam (recruiting since 1995, joined 2017), John White (Talent Sourcing Manager, joined 2012), and Partner Chris Miclot, (joined 2012). “In

article thumbnail

Leading in Pharma: a woman’s pathway

European Pharmaceutical Review

After moving to London in 2011, Ekaterina worked in global health and medical philanthropy, focusing on improving outcomes in maternal and child health. Article: The potential of tryptamines in treatment-resistant depression… The post Leading in Pharma: a woman’s pathway appeared first on European Pharmaceutical Review.

Leads 52
article thumbnail

The rise of prescription drug abuse and drug diversion

pharmaphorum

From 2010 to 2016, deaths from heroin overdoses increased rapidly, as those in the healthcare community understood the risks of opioid painkillers and reduced the number of prescriptions. There have also been numerous outbreaks of infections that stem from drug diversion activities by healthcare providers who tampered with injectable drugs.